Sharon Hunt, MD

Publication Details

  • Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era JOURNAL OF HEART AND LUNG TRANSPLANTATION Shiba, N., Chan, M. C., Valantine, H. A., Gao, S. Z., Robbins, R. C., Hunt, S. A. 2003; 22 (10): 1098-1106

    Abstract:

    Long-term survival after heart transplantation is common in the cyclosporine era. However, there are few data documenting pre-transplant/peri-operative factors predictive of truly long-term survival (>10 years). The purpose of this study is to identify factors associated with 10-year survival after heart transplantation.Our study population included 197 adults who survived >6 months and died <10 years after heart transplant (medium-term group) and 140 adults who survived >10 years after heart transplant (long-term group) between December 1980 and May 2001. A comparison was done between the two groups and we used multivariate analysis to identify which factors predicted 10-year survival.The long-term group had younger recipient and donor age, lower recipient body mass index at transplant, shorter waiting time and lower percentages of ischemic etiology/male recipient/non-white recipient. Kaplan-Meier plots of freedom from graft coronary artery disease and malignancy showed later onset patterns in the long-term group compared with the medium-term group. Multivariate analysis showed that white recipient, younger recipient and lower recipient body mass index at heart transplant were factors significantly associated with 10-year survival.Several pre-transplant/peri-operative factors were associated with survival beyond 10 years after heart transplantation. Stratified/tailored strategies based on these factors may be helpful to attain longer-term survival of recipients with higher risks.

    View details for DOI 10.1016/S1053-2498(02)01192-0

    View details for Web of Science ID 000185764400004

    View details for PubMedID 14550819

Stanford Medicine Resources:

Footer Links: